thrombo target Pages on BioPortfolio:

BioPortfolio - ThromboTargets Corporation
is responsible for Drug Development and Business Management; Thrombotargets Europe (Barcelona, Spain) projected for Target Identification, Lead Validation,
...
http://www.bioportfolio.com/biocorporate/31064-Thrombo_Targe...

Inhibitors of Gas6 as improved anti-thrombosis candidates
Gas6 therefore appears to represent a novel cardiovascular target with an excellent ..... of the carotid artery and; platelet-dependent thrombo embolism.
...
http://www.bioportfolio.com/LeadDiscovery/0246.htm...

BioPortfolio - Molecular Oncology
For many years, it has been recognised that venous thrombo-embolism (VTE). ... pdf | molecular oncology news | From single- to multi-target drugs in cancer ...
http://www.bioportfolio.com/biocorporate/7197-Molecular+Onco...

TGX-mAbFVIII-1, a type II monoclonal antibody to Factor VIII for ...
... to prevention of patients at risk for thrombo-embolic complications. .... Factor VIII has traditionally been avoided as an anti-coagulant target due to
...
http://www.bioportfolio.com/LeadDiscovery/thr004.htm...

Results from other life science and pharmaceutical sites:

Platelet GPIb complex as a target for anti-thrombo...[Thromb ...
Specific inhibition of platelet function is a major target of anti-thrombotic drug research. Platelet receptors are both accessible and specific but have ...
http://www.ncbi.nlm.nih.gov/pubmed/18327394...

Current Diagnosis of Venous Thrombo- embolism in Primary Care: A ...
Current Diagnosis of Venous Thrombo-. embolism in Primary Care: A Clinical .... target patient population is all adults who have a prob- ...
http://www.aafp.org/online/etc/medialib/aafp_org/documents/c...

Treatment of venous thrombo-embolism. [Baillieres Clin Obstet ...
Treatment of venous thrombo-embolism. ... Unfractionated heparin requires monitoring by the APTT (target ratio 1.5-2.5), and warfarin requires monitoring
by ...
http://www.ncbi.nlm.nih.gov/pubmed/9488789...

Antiphospholipid antibodies and subsequent thrombo...[JAMA. 2004 ...
... and comparing adjusted-dose warfarin (target international normalized ratio, ... Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive ...
http://www.ncbi.nlm.nih.gov/pubmed/14762036...

Evidence-Based Dentistry - Dental procedures can be undertaken ...
Data were extracted regarding management strategy, thrombo-embolic events ... Ironically, the lower-target patients, such as the atrial fibrillation group,
...
http://www.nature.com/ebd/journal/v6/n1/full/6400309a.html...

New anticoagulants for treatment of venous thrombo...[Arterioscler ...
... a long-acting synthetic pentasaccharide that is given subcutaneously on a once-weekly basis, and new oral anticoagulants that target thrombin or factor
...
http://www.ncbi.nlm.nih.gov/pubmed/18296593...

Management of menopause
Target organs of oestrogen. Bone; Urogenital; Vasomotor; Heart; Eyes; Teeth; Breast .... Thrombo-embolism. HRT and breast cancer. HRT and breast cancer ...
http://www.hku.hk/obsgyn/CME_CNE/powerpoint/MM.ppt...

Clinical implications of prostaglandin and thrombo...[N Engl J Med ...
1987]; [The prostaglandin and thromboxane system of the gastric mucosa as a target for protective and ulcerogenic drugs] [Wien Klin Wochenschr. ...
http://www.ncbi.nlm.nih.gov/pubmed/3045550...

Should patients with mitral stenosis and atrial fibrillation ...
atrial fibrillation or previous thrombo embolism. This conclusion is not the consequence of ... fibrillation: effectiveness of low intensity (INR target 2)
...
http://www.nature.com/pdffinder/10.1038/ncpcardio0612...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.